|
|
||||||||
1 Institute of Molecular Cardiobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205; and 2 Department of Physiology and Cell Biology and 3 Dorothy M. Davis Heart and Lung Institute, Ohio State University, Columbus, Ohio 43210
| |
ABSTRACT |
|---|
|
|
|---|
The progression of hypertension to
cardiac failure involves systemic changes that may ultimately affect
contractility throughout the heart. Spontaneous hypertensive heart
failure (SHHF) rats have depressed left ventricular (LV) function, but
right ventricular (RV) dysfunction is less well characterized.
Ultrathin (87 ± 5 µm) trabeculae were isolated from end-stage
failing SHHF rats and from age-matched controls. Under
near-physiological conditions (1 mM Ca2+, 37°C, 4 Hz),
developed force (in mN/mm2) was not significantly different
in SHHF LV and RV trabeculae and those of controls. SHHF LV
preparations displayed a negative force-frequency behavior (40 ± 7 vs. 23 ± 4 mN/mm2, 2 vs. 7 Hz); this relationship
was positive in SHHF RV preparations (27 ± 5 vs. 40 ± 6 mN/mm2) and controls (32 ± 6 vs. 44 ± 9 mN/mm2). The response to isoproterenol (10
6
M, 4 Hz) was depressed in SHHF LV preparations. The inotropic response
to hypothermia was lost in SHHF LV trabeculae but preserved in SHHF RV
trabeculae. Intracellular calcium measurements revealed impaired
calcium handling at higher frequencies in LV preparations. We conclude
that in end-stage failing SHHF rats, RV function is only marginally
affected, whereas a severe contractile dysfunction of LV myocardium is present.
contractile function; excitation-contraction coupling; heart failure; inotropic agents; hypertension
| |
INTRODUCTION |
|---|
|
|
|---|
ALTERED LOADING CONDITIONS can lead to remodeling of the heart and ultimately to the development of cardiac failure. A common pathway that can lead to such a remodeling of the heart is long-term hypertension. Initially, the sustained increased afterload mainly affects left ventricular (LV) function. However, on progression from a hypertrophied stage to heart failure, systemic changes may ultimately lead to a deterioration of right ventricular (RV) function. Evidence for such systemic changes includes the finding that infarction of the rat LV leads to contractile protein dysfunction in noninfarcted muscles isolated from the RV of these hearts (5). However, it remains unknown to what degree the RV is affected compared with dysfunction of the LV in end-stage heart failure, particularly under physiological conditions.
Spontaneous hypertensive heart failure (SHHF) rats provide a useful model to address the question of LV versus RV contractile function in advanced hypertension-induced heart failure. SHHF rats suffer from elevated systemic blood pressure and, on aging, develop heart failure that exhibits many features of the failing human heart (7). RV muscle function of these rats is known to be depressed at room temperature (20). Because a different temperature dependence exists for contraction, relaxation, and calcium handling (16), it is unknown how these results relate to a dysfunction under physiological conditions. To address the question of the degree to which RV function is affected under conditions that mimic those in vivo, we compared contractile function and calcium handling in muscles isolated from the LV and RV of SHHF rats in end-stage heart failure at physiological temperature and frequency. The results reveal striking functional differences between LV and RV myocardium in SHHF rats.
| |
METHODS |
|---|
|
|
|---|
Muscle preparation and experimental setup. Male SHHF rats (23) were housed until they developed severe heart failure at 18-19 mo of age. This was evident by clinical signs such as severe lethargic behavior, labored and high-frequency breathing (>200 breaths/min), and edema. One rat died before tissue could be harvested. Aged-matched control rats (n = 10, 18-22 mo, Wistar) were treated and housed under identical conditions. The investigation conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, Revised 1996). Genotyping identified the vast majority (11 of 14 genotyped) of SHHF animals as "true leans," i.e., having a complete absence of the cp gene. No obvious differences were observed between the three heterozygous animals and the true lean animals with respect to the severity of heart failure. Rats were anesthetized by intraperitoneal injection of 1.0 ml/kg pentobarbital sodium (360 mg/ml). After intracardiac heparinization, hearts were rapidly excised and placed in Krebs-Henseleit buffer containing (in mM) 120 NaCl, 5 KCl, 2 MgSO4, 1.2 NaH2PO4, 20 NaHCO3, 0.25 Ca2+, and 10 glucose (pH 7.4). Additionally, 20 mM 2,3-butanedione monoximine (BDM) was added to the dissection buffer to minimize cut-end trauma. The effects of short-term BDM exposure were reversible (13, 17). Heart weight (wet, in mg) and total body weight (in g) were recorded for each rat. Hearts were cannulated via the ascending aorta and retrogradely perfused with the same buffer equilibrated with 95%O2-5% CO2. Blood was thoroughly washed out, and thin, uniform, nonbranched trabeculae from the RV (SHHF: n = 14; control: n = 7) and/or the LV (SHHF: n = 15; control: n = 4) were carefully dissected, leaving a block of tissue at one end from the ventricular wall and a small part of the valve (or second block of tissue depending on the position of the trabecula) at the other attached to the preparation to facilitate mounting. Dimensions of the muscles (n = 40) were measured with a calibration reticule in the ocular of the dissection microscope (×40, resolution ~10 µm): width 218 ± 11 µm, thickness 86 ± 5 µm, and length 2.34 ± 0.09 mm. Cross-sectional area was calculated assuming an ellipsoid shape; dimensions were comparable in the various experimental groups.
Muscles were mounted between a platinum-iridium basket-shaped extension of a force transducer and a hook connected to a micromanipulator. This attachment method minimizes end-damage compliance of the muscle (2, 13, 15, 17, 24) and prevents excessive loss of force throughout the experimental protocols. Muscles were perfused with the same buffer as above (except that BDM was omitted) at 22.5°C and stimulated at 0.5 Hz, extracellular calcium concentration ([Ca2+]o) was raised to 1.0 mM, and muscles were allowed to stabilize for at least 30 min before the experimental protocol was initiated. Muscles were stretched to a length at which a small increase in length resulted in about equal increases in resting tension and active developed tension. This length, which is slightly below the length at which active force development is maximal, was selected to be comparable to the maximally attained length in vivo (~2.2 µm sarcomere length) (22).Measurement of intracellular calcium concentration in RV trabeculae. In a subset of experiments (n = 8 muscles, 4 LV and 4 RV), the intracellular calcium concentration ([Ca2+]i) was measured as previously described (1, 2, 6, 12, 16). Briefly, after the muscle had stabilized (at 1.0 mM Ca2+, 22.5°C, and 0.5 Hz) for 30 min, [Ca2+]o was reduced to 0.25 mM and stimulation was stopped. Background fluorescence (340, 358, and 380 nm) was collected at both 22.5°C and 37.5°C. Fura 2 pentapotassium salt (Molecular Probes, Eugene, OR) was microinjected iontophoretically into one cell and allowed to spread throughout the muscle via the gap junctions. After fura 2 loading, stimulation was restarted and [Ca2+]i was determined by alternating illumination at 340 and 380 nm. We used a heat-exchange system to achieve rapid (<2 s) switching to 37.5°C from 22.5°C. Limiting exposure to high temperatures to short intervals (4-6 min) enabled us to measure [Ca2+]i at body temperature by virtually eliminating the loss of dye that has thus far undermined the assessment of calibrated [Ca2+]i transients at 37.5°C. [Ca2+]i was calculated as described previously (1, 2, 6, 16). It was shown that the Kd for Ca2+ binding to fura 2 displays very little temperature dependence (8, 25); we therefore used the previously obtained Kd value in the present experimental setup (1, 20). Fluorescence was collected at 510 nm by a photomultiplier tube (R1527; Hamamatsu). The output of the photomultiplier was filtered at 300 Hz, collected by an analog-to-digital converter, and stored in a computer for off-line analysis.
Experimental protocols.
To determine the effects of temperature on contractile behavior, force
was recorded while the temperature was slowly increased (2.5°C
intervals) from 22.5 to 37.5°C. The changes in temperature were slow
enough to be considered steady state (<0.5°C/min). To ensure the
latter, experiments were repeated in the opposite direction (from 37.5 to 22.5°C), and no hysteresis was observed. Force-frequency behavior
was measured by increasing the frequency of stimulation from 0.5 to 10 Hz (at 37.5°C). To test the
-adrenergic response, cumulative
concentration curves were obtained with isoproterenol (10
9-10
6 M) at a baseline frequency of
4 Hz at 37.5°C. Contractile parameters were recorded as soon as they
had stabilized.
Data analysis and statistics. In all experiments, developed force (Fdev) and diastolic force (Fdia) were determined and normalized to the cross-sectional area of the muscle. Additionally, to assay the timing of force decay, the time from peak force to 50% relaxation (RT50%) was determined. Multiple analysis of variance was used to determine significant differences between the interventions, with post hoc t-test when appropriate. A two-sided P value of <0.05 was considered significant. Data are presented as means ± SE unless otherwise stated.
| |
RESULTS |
|---|
|
|
|---|
Characteristics of SHHF animals in end-stage failure. At the time of death, all 22 SHHF rats were in an advanced stage of heart failure with severe lethargic behavior, rapid shallow respirations, and edema. In addition, several of these rats had left atrial thrombi, which were not observed in any of the age-matched animals. As a more quantifiable parameter of hypertrophy and/or heart failure, we measured the heart weight-to-body weight ratio (HW/BW). SHHF rats had significantly larger hearts and lower body weights, resulting in a much higher HW/BW (5.4 ± 0.2 mg/g) compared with control animals (3.1 ± 0.1 mg/g; P < 0.001).
Effects of temperature.
In age-matched controls, none of the contractile parameters in any of
the protocols was significantly different between RV and LV. Thus, in
normal animals of this age, contractile function is very similar in the
RV and LV. Under baseline conditions of 1.0 mM
[Ca2+]o and a stimulation frequency of 0.5 Hz, at room temperature the active Fdev of both SHHF RV and
LV trabeculae was depressed compared with that of the age-matched
controls (P < 0.05; Fig. 1). The observation of depressed RV
muscle function in this study confirms that observed previously in this
animal model (20). Although we do not see major
differences in the time course of twitch contractions, the present data
further reveal that the function of LV trabeculae is also depressed
compared with age-matched controls. Next, we investigated whether this
depression of contractile function is present at physiological
temperature. Therefore, we slowly raised the temperature of the
perfusate to 37.5°C and measured contractile function at 2.5°C
intervals. SHHF RV and all control trabeculae behaved as expected
(23); with increasing temperature, Fdev
remained relatively unchanged up to 30°C and thereafter declined to
~30-40% of the values obtained at 22.5°C (reversed
hypothermic inotropy; Fig. 2).
Surprisingly, despite the similar behavior of SHHF LV and RV trabeculae
at room temperature, SHHF LV trabeculae did not decline in
Fdev with increasing temperature, as would be expected.
Active Fdev actually increased up to 35°C
(P < 0.05 vs. 22.5°C at 30, 32.5, and 35°C) and
then slightly declined. At 37.5°C, Fdev was not
significantly different from that observed at 22.5°C, in sharp
contrast to SHHF RV and control trabeculae.
|
|
Force-frequency relationship.
At the low stimulation frequency of 0.5 Hz and body temperature, SHHF
LV trabeculae displayed higher Fdev (43.7 ± 7.7 mN/mm2) than SHHF RV trabeculae (24.3 ± 4.6, mN/mm2; P < 0.05). However, when we
increased the frequency to 4 Hz, approaching the physiological
frequency of the rat, all four groups had similar forces (Fig.
3). SHHF LV trabeculae displayed a
negative contractile response to increasing frequency, whereas both the SHHF RV and control trabeculae exhibited an increase in
Fdev when paced more rapidly up to ~6-7 Hz (ranging
from 5 to 10 Hz). Thus the optimum frequency was near 6-7 Hz in
SHHF RV and control trabeculae but only 1 Hz (range 0.5-3 Hz) in
SHHF LV trabeculae. At a frequency of 9-10 Hz, which is maximal
for a rat in vivo (3), the difference between the SHHF LV
and all other groups was most prominent; SHHF LV trabeculae decreased
to 40 ± 21% of their initial force at 0.5 Hz, whereas SHHF RV
trabeculae significantly increased (actually almost doubled their
initial individual values). Twitch timing parameters (Fig.
4) were quite similar; the only
significant difference observed between SHHF LV and SHHF RV
preparations was in regard to time to peak tension, which was
significantly higher in SHHF LV preparations at all frequencies, and a
faster rate of relaxation in RV preparations at 0.5 and 10 Hz (vs. LV
or control).
|
|
-Adrenergic response.
Next, we investigated the response to isoproterenol. A reduced
-adrenergic response is a classic feature of end-stage heart failure
(4). Starting from baseline conditions (37.5°C, 4 Hz, 1 mM [Ca2+]o), a cumulative
concentration-response curve was obtained by raising the isoproterenol
concentration stepwise from 10
9 to 10
6 M. For this protocol, we pooled the control trabeculae (n = 2 LV and n = 7 RV; no difference between LV and RV).
No differences in EC50 [SHHF LV (n = 6):
18 ± 11 nM; SHHF RV (n = 7): 24 ± 12 nM;
control (n = 9): 27 ± 9 nM] were observed
between the groups (calculated as the average of the individual curve
fits). However, the maximal response to isoproterenol was significantly
reduced in the SHHF LV specimens (Fig.
5); in SHHF LV trabeculae,
Fdev increased only 23.8 mN/mm2 on average
compared with 43.1 mN/mm2 in SHHF RV and 47.3 mN/mm2 in control trabeculae.
|
Calcium transients.
In a subset of experiments (n = 8; 4 SHHF RV and 4 SHHF
LV), we measured intracellular calcium transients. Figure
6 shows experimental records from
individual RV and LV muscles at 4 and 10 Hz; Fig.
7 shows average values for calcium
transient amplitude and developed force. In RV trabeculae, at 10 Hz the
amplitude of the calcium transient increased compared with 4 Hz but
force remained unaltered, whereas diastolic calcium was slightly
elevated (from 180 ± 50 to 250 ± 60 nM; P < 0.05). In sharp contrast, in LV trabeculae, Fdev
decreased on an increase in stimulation frequency from 4 to 10 Hz. This
was accompanied by a larger elevation of diastolic calcium (from
210 ± 40 to 320 ± 60 nM; P < 0.05) without a significant change in the amplitude of the calcium transient. Thus,
at higher frequencies, more calcium appears to be required to maintain
a similar amount of force in SHHF RV trabeculae; failure to increase
calcium with frequency in SHHF LV preparations resulted in a loss of
force. However, the rather small difference in the change of the
calcium transient amplitude may not fully explain the effects on twitch
force amplitude. As can be seen in Fig. 6, bottom (and in
Fig. 3), Fdev clearly declined considerably in the LV
trabeculae but not in the RV trabeculae. Thus, besides the obvious
alterations in calcium handling, altered myofilament properties may
potentially play an additional role in the contractile dysfunction
observed in failing SHHF myocardium.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The goal of the present study was to conduct a comparison of contractile function of right and left myocardium from SHHF rats that develop heart failure due to long-term hypertension.
Contractile dysfunction. We found that the conclusions depended strongly on experimental conditions. Under conditions designed to mimic those occurring in vivo, we observed severe contractile dysfunction of LV myocardial preparations. In contrast, RV preparations displayed little dysfunction and behaved very similarly to age-matched preparations from healthy rats. In contrast, at low rates of stimulation and at room temperature, both RV and LV SHHF preparations developed significantly less force than respective control preparations. The magnitude of this cardiac depression at room temperature was similar to that observed previously (20). Interestingly, at body temperature, at a stimulation frequency near the lowest achievable in a rat in vivo (4 Hz), active Fdev was similar in SHHF and control preparations as well as between the RV and LV. At higher, more physiological frequencies (5-9 Hz), it became apparent that LV function was severely depressed; active Fdev decreased considerably when frequency was increased. RV function displayed a normal positive force-frequency relationship similar to that of age-matched controls and previous studies on isolated rat myocardium under these physiologically relevant conditions (16, 17). Compared with controls, RV preparations from SHHF rats were not significantly depressed under near-physiological conditions. Thus, except for the depressed contractile behavior at nonphysiological temperature and stimulation frequencies, a finding consistent with Perez et al. (20), RV function was similar to that of age-matched controls.
LV dysfunction was readily apparent in this study. The characteristic positive force-frequency behavior of healthy rat myocardium (16, 17) was absent, or even negative, in SHHF LV preparations. In addition, the amplitude of the intracellular calcium transients was depressed at higher frequencies, isoproterenol response was reduced in amplitude, time to peak tension was prolonged, and normal hypothermic inotropism was absent. In addition, diastolic calcium levels were elevated at physiologically relevant frequencies by 110 nM on average but only by 70 nM on average in RV preparations. These observations are in line with prior assessments of LV function of the SHHF rat in whole heart models, which showed depressed contractions and the development of alternans at frequencies >6 Hz (19). In addition, many aspects of the SHHF LV dysfunction observed here are reminiscent of failing human myocardium. Blunted or negative force-frequency behavior (18, 21), reduced
-adrenergic response
(4), and impaired calcium handling (9, 10)
are hallmarks of end-stage heart failure. Unfortunately, few data are
presently available regarding contractile behavior of RV myocardium from human end-stage failing hearts for comparison with the present study. It was shown, however, that a large number of small RV preparations from end-stage failing human hearts displayed a positive force-frequency behavior (reminiscent of healthy myocardium) in two
recent studies (11, 14). Thus, also in human end-stage heart failure, RV contractile function may be significantly less impaired than that in LV myocardium.
Calcium handling. Despite the clear differences in contractile function of LV versus RV preparations, calcium handling may not necessarily be the sole culprit underlying this dysfunction. In healthy rat myocardium, an increase in frequency within the physiological range results in a parallel increase in calcium transient amplitude and maximal twitch force (16). In end-stage failing SHHF rats, despite an increase in calcium transient amplitude, RV preparations could not generate more force at 10 Hz compared with 4 Hz. The absence of an increase in calcium with increasing stimulation frequency in SHHF LV preparations resulted in a loss of contractile force. Thus changes in the calcium transient may not solely explain the depressed contractions compared with normal myocardium as described previously (16). Contractile behavior critically depends on two major factors, calcium handling and myofilament responsiveness. Thus myofilament properties are also altered in this model of heart failure. This would be in line with results obtained from tetanized SHHF trabeculae at room temperature; these experiments revealed a depressed maximal force development (20). However, a potential myofilament problem does not directly explain the difference between LV and RV preparations but could possibly affect function of preparations of both ventricles slightly differently. At a higher stimulation rate, the changing relaxation balance between intracellular calcium decline and force decline shifts the governing of relaxation to the myofilament properties (16). Because the twitch timing properties are somewhat different in RV and LV preparations, it is not impossible that an underlying myofilament dysfunction (20) may have a larger impact on LV preparations than on RV preparations, contributing to the observed differences. However, if such a myofilament component of dysfunction did contribute, this would clearly be a minor effect compared with the obvious defect in calcium handling.
The loss of hypothermia-induced inotropy in SHHF LV trabeculae may likewise be due to altered myofilament abnormalities. Compared with body temperature, at room temperature Fdev was not higher, as it was in control and SHHF RV trabeculae. Although a more focused investigation would be needed to unambiguously determine the relative roles of calcium cycling and myofilament abnormalities, we speculate that myofilament alterations may result in an altered Q10 for cross-bridge cycling kinetics, causing the observed loss of hypothermia-induced inotropy. Altered temperature dependence of cross-bridge cycling kinetics would also fit with the observed timing parameters; time to peak tension was slowed at body temperature but not at room temperature in SHHF LV trabeculae, whereas such changes were not observed in SHHF RV trabeculae.Technical limitations. Although we have now shown the feasibility of assessing cytosolic calcium transients from iontophoretically loaded cardiac trabeculae at physiological temperature, the short period over which these can be collected unfortunately prevents an in vivo calibration that typically takes several hours. Thus, because it is impossible to obtain an in situ Kd, we currently have to rely on the previously assessed Kd for fura-Ca2+ obtained at room temperature to calculate free calcium from the fluorescence ratio of 340 to 380 nm. It has been reported that the Kd of fura 2 displays very little temperature dependence (8, 25). However, even if a shift in the Kd with temperature were to occur, this would not affect the central conclusions. Such a shift in Kd would alter the exact calcium concentration calculated from the ratio equally in all groups; thus the central conclusions regarding the calcium transient observations (difference in amplitude at high stimulation rates) would not be affected.
In summary, in the SHHF rat, LV contractile dysfunction is much more prominent than in the RV. Although the Fdev of SHHF LV preparations is comparable to that of controls and SHHF RV preparations at subphysiological frequencies, at higher, more physiological frequencies baseline contractility and
-adrenergic responsiveness are severely impaired in SHHF LV preparations. This indicates a severe
reduction in cardiac reserve of SHHF LV preparations in contrast to
SHHF RV preparations.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by National Heart, Lung, and Blood Institute Grants RO1-HL-44065 (to E. Marbán) and RO1-HL-48835 (to R. A. Altschuld). L. B. Stull was supported by Fellowship Training Grant 2-T32-HL-07581-1. E. Marbán holds the Michel Mirowski, M.D., Professorship of Cardiology of the Johns Hopkins University.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: P. M. L. Janssen, Dept. of Physiology and Cell Biology, Ohio State Univ., 302 Hamilton Hall, 1645 Neil Ave., Columbus, OH 43210 (E-mail: janssen.10{at}osu.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published November 7, 2002;10.1152/ajpheart.01061.2001
Received 4 December 2001; accepted in final form 31 October 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Backx, PH,
Gao WD,
Azan-Backx MD,
and
Marban E.
The relationship between contractile force and intracellular [Ca2+] in intact rat cardiac trabeculae.
J Gen Physiol
105:
1-19,
1995
2.
Backx, PH,
and
Ter Keurs HE.
Fluorescent properties of rat cardiac trabeculae microinjected with fura-2 salt.
Am J Physiol Heart Circ Physiol
264:
H1098-H1110,
1993
3.
Basile-Filho, A,
Campos A,
Esteves S,
Bordin S,
and
Mantovani M.
Influence of subacute starvation on cardiac response to isoproterenol in rats.
Nutrition
7:
280-282,
1991[Web of Science][Medline].
4.
Bristow, MR,
Ginsburg R,
Minobe W,
Cubicciotti RS,
Sageman WS,
Lurie K,
Billingham ME,
Harrison DC,
and
Stinson EB.
Decreased catecholamine sensitivity and
-adrenergic-receptor density in failing human hearts.
N Engl J Med
307:
205-211,
1982[Abstract].
5.
De Tombe, PP,
Wannenburg T,
Fan D,
and
Little WC.
Right ventricular contractile protein function in rats with left ventricular myocardial infarction.
Am J Physiol Heart Circ Physiol
271:
H73-H79,
1996
6.
Gao, WD,
Backx PH,
Azan-Backx M,
and
Marban E.
Myofilament Ca2+ sensitivity in intact versus skinned rat ventricular muscle.
Circ Res
74:
408-415,
1994
7.
Gerdes, AM,
Onodera T,
Wang X,
and
McCune SA.
Myocyte remodeling during the progression to failure in rats with hypertension.
Hypertension
28:
609-614,
1996
8.
Groden, DL,
Guan Z,
and
Stokes BT.
Determination of fura-2 dissociation constants following adjustment of the apparent Ca-EGTA association constant for temperature and ionic strength.
Cell Calcium
12:
279-287,
1991[Web of Science][Medline].
9.
Gwathmey, JK,
Copelas L,
MacKinnon R,
Schoen FJ,
Feldman MD,
Grossman W,
and
Morgan JP.
Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure.
Circ Res
61:
70-76,
1987
10.
Hasenfuss, G,
Mulieri LA,
Leavitt BJ,
Allen PD,
Haeberle JR,
and
Alpert NR.
Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy.
Circ Res
70:
1225-1232,
1992
11.
Janssen, PML,
Datz N,
Zeitz O,
and
Hasenfuss G.
Levosimendan improves diastolic and systolic function in failing human myocardium.
Eur J Pharmacol
404:
191-199,
2000[Web of Science][Medline].
12.
Janssen, PML,
and
de Tombe PP.
Uncontrolled sarcomere shortening increases intracellular Ca2+ transient in rat cardiac trabeculae.
Am J Physiol Heart Circ Physiol
272:
H1892-H1897,
1997
13.
Janssen, PML,
and
Hunter WC.
Force, not sarcomere length, correlates with prolongation of isosarcometric contraction.
Am J Physiol Heart Circ Physiol
269:
H676-H685,
1995
14.
Janssen, PML,
Lehnart SE,
Prestle J,
and
Hasenfuss G.
Preservation of contractile characteristics of human myocardium in multi-day cell culture.
J Mol Cell Cardiol
31:
1419-1427,
1999[Web of Science][Medline].
15.
Janssen, PML,
Lehnart SE,
Prestle J,
Lynker JC,
Salfeld P,
Just H,
and
Hasenfuss G.
The trabecula culture system: a novel technique to study contractile parameters over a multiday time period.
Am J Physiol Heart Circ Physiol
274:
H1481-H1488,
1998
16.
Janssen, PML,
Stull LB,
and
Marban E.
Myofilament properties comprise the rate-limiting step for cardiac relaxation at body temperature in the rat.
Am J Physiol Heart Circ Physiol
282:
H499-H507,
2002
17.
Layland, J,
and
Kentish JC.
Positive force- and [Ca2+]i-frequency relationships in rat ventricular trabeculae at physiological frequencies.
Am J Physiol Heart Circ Physiol
276:
H9-H18,
1999
18.
Mulieri, LA,
Hasenfuss G,
Leavitt B,
Allen PD,
and
Alpert NR.
Altered myocardial force-frequency relation in human heart failure.
Circulation
85:
1743-1750,
1992
19.
Narayan, P,
McCune SA,
Robitaille PM,
Hohl CM,
and
Altschuld RA.
Mechanical alternans and the force-frequency relationship in failing rat hearts.
J Mol Cell Cardiol
27:
523-530,
1995[Web of Science][Medline].
20.
Perez, NG,
Hashimoto K,
McCune S,
Altschuld RA,
and
Marban E.
Origin of contractile dysfunction in heart failure: calcium cycling versus myofilaments.
Circulation
99:
1077-1083,
1999
21.
Phillips, PJ,
Gwathmey JK,
Feldman MD,
Schoen FJ,
Grossman W,
and
Morgan JP.
Post-extrasystolic potentiation and the force-frequency relationship: differential augmentation of myocardial contractility in working myocardium from patients with end-stage heart failure.
J Mol Cell Cardiol
22:
99-110,
1990[Web of Science][Medline].
22.
Rodriguez, EK,
Hunter WC,
Royce MJ,
Leppo MK,
Douglas AS,
and
Weisman HF.
A method to reconstruct myocardial sarcomere lengths and orientations at transmural sites in beating canine hearts.
Am J Physiol Heart Circ Physiol
263:
H293-H306,
1992
23.
Shattock, MJ,
and
Bers DM.
Inotropic response to hypothermia and the temperature-dependence of ryanodine action in isolated rabbit and rat ventricular muscle: implications for excitation-contraction coupling.
Circ Res
61:
761-771,
1987
24.
Ter Keurs, HE,
Rijnsburger WH,
van Heuningen R,
and
Nagelsmit MJ.
Tension development and sarcomere length in rat cardiac trabeculae. Evidence of length-dependent activation.
Circ Res
46:
703-714,
1980
25.
Uto, A,
Arai H,
and
Ogawa Y.
Reassessment of fura-2 and the ratio method for determination of intracellular Ca2+ concentrations.
Cell Calcium
12:
29-37,
1991[Web of Science][Medline].
This article has been cited by other articles:
![]() |
G.-Y. Wang, D. T. McCloskey, S. Turcato, P. M. Swigart, P. C. Simpson, and A. J. Baker Contrasting inotropic responses to {alpha}1-adrenergic receptor stimulation in left versus right ventricular myocardium Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H2013 - H2017. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G Taylor, L. D Parilak, M. M LeWinter, and H. J Knot Quantification of the rat left ventricle force and Ca2+-frequency relationships: similarities to dog and human Cardiovasc Res, January 1, 2004; 61(1): 77 - 86. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |